ArticleClinicoEconomics and outcomes research : CEOR2013

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4.

Claudio Borghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.